News
10-09-2008, 03:21 AM
deCODE genetics (Nasdaq: DCGN) announced the launch of deCODE BreastCancer(TM), a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can speak with her physician about a genetic test to better understand her lifetime risk of developing the common forms of the disease.
More... (http://www.medicalnewstoday.com/articles/124799.php)
More... (http://www.medicalnewstoday.com/articles/124799.php)